<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04949451</url>
  </required_header>
  <id_info>
    <org_study_id>TRIMM062021</org_study_id>
    <nct_id>NCT04949451</nct_id>
  </id_info>
  <brief_title>Time Restricted Feeding, Muscle, and Metabolism</brief_title>
  <acronym>TRIMM</acronym>
  <official_title>Time Restricted Feeding Intervention for Muscle and Metabolic Health (TRIMM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas, Fayetteville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas, Fayetteville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effective nutrition strategies for combatting and/or preventing obesity still need to be&#xD;
      identified. This has been the case despite the numerous and different approaches that have&#xD;
      been taken. Potential targets for combatting/preventing obesity have been identified, but&#xD;
      long-term solutions have not emerged. This study uses time restricted feeding to study the&#xD;
      role of dietary protein in obesity prevention and/or treatment. The objectives are to&#xD;
      determine the role of skeletal muscle mass as a driver of energy-sensing mechanisms and&#xD;
      peripheral signals that regulate appetite and energy intake in overweight and obese adults&#xD;
      and to determine the effects of protein timing on muscle mass to regulate appetite and energy&#xD;
      intake in overweight and obese adults.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 13, 2021</start_date>
  <completion_date type="Anticipated">May 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>Change is being assessed at baseline and final day (day 120) of the intervention.</time_frame>
    <description>Body composition measured using dual x-ray absorptiometry to determine the ration of lean/fat-free mass to fat mass.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Whole body protein turnover</measure>
    <time_frame>Change is being assessed at baseline and final day (day 120) of the intervention.</time_frame>
    <description>Whole body protein turnover will be measured using 15N-alanine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle mass</measure>
    <time_frame>Change is being assessed at baseline and final day (day 120) of the intervention.</time_frame>
    <description>Muscle mass will be measured using D3-creatine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks.</time_frame>
    <description>Body weight will be measured in kilograms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep</measure>
    <time_frame>Change is being assessed at baseline and 12 weeks</time_frame>
    <description>Sleep will be assessed using wrist Actigraphy for sleep duration and total time in bed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep Quality</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks</time_frame>
    <description>Sleep quality will be measured using the Pittsburgh Sleep Quality Index survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mood</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks</time_frame>
    <description>Mood will be assessed using the Profile of Mood States Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grit</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks</time_frame>
    <description>Grit will be assessed using the grit questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported physical activity</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks</time_frame>
    <description>Physical activity will be measured using the iPAQ survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks</time_frame>
    <description>Dietary intake will be measured using weighed, 3-day food records</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting glucose</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks</time_frame>
    <description>Glucose will be measured as mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hand grip</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks</time_frame>
    <description>Hand grip will be measured using a dynamometer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amino acids and metabolites</measure>
    <time_frame>Change is being assessed at baseline, 4, 8, and 12 weeks</time_frame>
    <description>Blood will be collected and plasma amino acids and metabolites will be assessed using commercially available kit for amino acid analysis for all circulating amino acids.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>TRF-C</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Follows time restricted feeding protocol.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRF-P</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Follows time restricted feeding protocol, consumes protein supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRF-S</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Follows time restricted feeding protocol, consumes ketogenic supplement</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Whey protein supplement</intervention_name>
    <description>Participants consume whey protein at the beginning of the eating period.</description>
    <arm_group_label>TRF-P</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ketogenic aid</intervention_name>
    <description>Participants consume ketogenic aid upon waking.</description>
    <arm_group_label>TRF-S</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control group - time restricted feeding only</intervention_name>
    <description>Time restricted feeding.</description>
    <arm_group_label>TRF-C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Resides in Northwest Arkansas&#xD;
&#xD;
          -  Age 25-50 years&#xD;
&#xD;
          -  BMI &gt; 25&#xD;
&#xD;
          -  All ethnicities&#xD;
&#xD;
          -  Female and male&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Food allergies&#xD;
&#xD;
          -  Pregnant or breastfeeding&#xD;
&#xD;
          -  Dietary restrictions (e.g. vegetarian, vegan, etc.)&#xD;
&#xD;
          -  Trying to lose weight in last 3 months&#xD;
&#xD;
          -  Pre-existing health conditions related to obesity (e.g. cardiovascular disease,&#xD;
             diabetes, hypertension)&#xD;
&#xD;
          -  Prescription medications related to heart disease or type 2 diabetes&#xD;
&#xD;
          -  Fear of needles&#xD;
&#xD;
          -  Smoker or vaping&#xD;
&#xD;
          -  Currently taking protein supplements or other nutritional supplements which may&#xD;
             interfere with study outcomes&#xD;
&#xD;
          -  Consumes &gt;4 alcoholic beverages per week&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jamie Baum, PhD</last_name>
    <phone>479-575-4474</phone>
    <email>baum@uark.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Arkansas</name>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72704</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie I Baum, PhD</last_name>
      <phone>479-575-4474</phone>
      <email>baum@uark.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Arkansas, Fayetteville</investigator_affiliation>
    <investigator_full_name>Jamie Baum</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

